pharma-congress-molecular-medicine-2018-tracks

6 / 10

Page 21
O c t o b e r 1 9 - 2 0 , 2 0 1 8 | T o k y o , J a p a n
Pharma Congress 2018 & Molecular Medicine 2018
& Psychiatric Disorders 2018 Asian Journal of Biomedical and Pharmaceutical Sciences | ISSN: 2249-622X| Volume 8
International Conference on
PHARMACEUTICS AND NOVEL DRUG DELIVERY SYSTEMS
19th International Conference on
CELLULAR AND MOLECULAR MEDICINE
19th Annual Congress on
PSYCHIATRY AND PSYCHIATRIC DISORDERS
&
&
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
YEARS
Muhammad Sayed Inam, Asian J Biomed Pharmaceut Sci 2018, Volume 8 | DOI: 10.4066/2249-622X-C3-008
PSYCHIATRIC MORBIDITY AMONG THE
PATIENT OF FIRST EVER ISCHAEMIC
STROKE
Muhammad Sayed Inam
Upazilla Health and Family Planning Officer, Bangladesh
Stroke is the most common cause of mortality worldwide and a serious
cause of disability in the community. Stroke affects not only physical
but also emotional, psychological, cognitive, and social aspects of patients.
Some of the neuropsychiatric disorders associated with stroke include post
stroke depression (PSD), bipolar disorder, anxiety disorder, apathy without de-
pression, psychotic disorder, pathological affect and catastrophic reaction.
Previous studies showed that co-morbid psychiatric disorders significantly
increase medical costs. Aims and objectives: To evaluate psychiatric morbid-
ity among the patients of first ever ischemic stroke.
Materials and Methods: This cross sectional comparative study was carried
out in the Department of Psychiatry, Sylhet MAG Osmani Medical College
Hospital, Sylhet during the period from 1st July 2013 to 30th June 2014. Sixty
six ischaemic stroke patients of first attack between 2 weeks to 2 years of
stroke, aged above 18 years irrespective of sex and 66 accompanying healthy
person of the patients and other patients without any kind of stroke matching
age and sex fulfilling inclusion and exclusion criteria were taken in Group-A
and Group-B respectively. Exclusion criteria were patients with transient
ischaemic attack, haemorrhagic stroke, previous stroke, head injury, known
psychiatric disorder, serious cognitive impairment and other chronic diseas-
es that may cause psychiatric morbidity. Diagnosis of ischaemic stroke was
made in these patients by the consultant neurologists reviewing the history,
clinical examination and accompanying investigations reports specially CT
scan of brain. Psychiatric assessment was done using General Health Ques-
tionnaire (GHQ12) as screening tool. All GHQ12 positive cases were evaluat-
ed using mental state examination and recorded in a MSE sheet. Diagnosis
of psychiatric disorders of all respondents was confirmed by psychiatrist ac-
cording to DSM-5 criteria.
Results: The patients with ischaemic stroke and control subjects were sim-
ilar in age [57.6 (SD ± 5.5) years vs 57.1 (SD ± 4.5) years; p>0.130] and sex
[48 (72.7%) male and 18 (27.3%) female vs 45 (68.2%) male and 21 (31.8%)
female; p=0.567]. Co-morbid psychiatric disorder was found in 23 (34.8%)
patients of ischaemic stroke and 9 (13.6%) control subjects. The co-morbid
psychiatric disorder was significantly higher in patients of ischaemic stroke
than that of control g subjects (p=0.004). Co-morbid specific psychiatric dis-
orders were generalized anxiety disorder in 9 (13.6%) and major depressive
disorder in 14 (21.2%) in stroke group; while co-morbid specific psychiatric
disorders were generalized anxiety disorder in 2 (3.0%) and major depres-
Muhammad Sayed Inam has dome specialization from
Upazilla Health and he is a Family Planning Officer, Ban-
gladesh he carried out his research in the Department of
Psychiatry of Sylhet MAG Osmani Medical College Hos-
pital.
BIOGRAPHY
sive disorder in 7 (10.6%) respondents in control
group (p<0.013).
Conclusion: Co-morbid psychiatric disorders are
quite common among patients with first ever
ischaemic stroke in the form of major depres-
sive disorder and generalized anxiety disorder.
Therefore, attention should be paid to the anxi-
ety and depressive symptoms in stroke units and
try to relieve the patients’ emotional stress and
personal suffering, which could improve their
neurological outcome.